3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Melanoma
2
Vaping
1
Uterine Cervical Dysplasia
1
Smoking Cessation
1
Nevus, Spindle Cell
1
Nevus, Pigmented
1
Nevus, Epithelioid and Spindle Cell
1
Nevus, Blue
1
Nevus
1
Nevi and Melanomas
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Dysplastic Nevus Syndrome
1
Cutaneous Squamous Cell Carcinoma
1
Breast Neoplasms
1
Agnosia
1
Interventions
Cyclophosphamide
41
Peripheral Blood Stem Cell Transplantation
40
fludarabine phosphate
36
Whole-Body Irradiation
27
Mycophenolic Acid
27
Tacrolimus
23
Busulfan
23
Cyclosporine
22
Antilymphocyte Serum
20
Etoposide
17
Methotrexate
16
Filgrastim
16
Melphalan
14
romidepsin
13
Radiotherapy
13
Flow Cytometry
12
Methylprednisolone
10
Brentuximab Vedotin
10
Therapeutics
9
Psychiatric Rehabilitation
9
Lenalidomide
8
pembrolizumab
7
fludarabine
7
Sirolimus
7
Rituximab
7
Bortezomib
7
Bexarotene
7
mogamulizumab
6
Polymerase Chain Reaction
6
Gemcitabine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, T-Cell, Cutaneous
×
Transdermal Patch
×
Clear all
NCT02192021
2024-08-09
MNA-D
University of Pittsburgh
Phase 1
Completed
20 enrolled